Kolexia
Sermet Isabelle
Pédiatrie
Hôpital Necker Enfants Malades
Paris, France
255 Activités
0 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Mucoviscidose Fibrose Maladies pulmonaires COVID-19 Inflammation Infections à Pseudomonas Infections de l'appareil respiratoire Maladies osseuses Infections à staphylocoques

Industries

Vertex
24 collaboration(s)
Dernière en 2023
Meda Pharma
2 collaboration(s)
Dernière en 2020
WPP HEALTH FRANCE
2 collaboration(s)
Dernière en 2020
VIATRIS MEDICAL
1 collaboration(s)
Dernière en 2022

Dernières activités

BIO-CFTR: Personalized Therapy of Cystic Fibrosis: Set-up of Response Markers
Essai Clinique (Hôpital Necker Enfants Malades)   08 mars 2024
FIBROMARS: Impact of Loss-of-function Mutations of Genes Encoding Cytosolic Aminoacyl-tRNA Synthetases on Protein Translation and Responses to Cellular Stress
Essai Clinique (Assistance publique – Hôpitaux de Paris)   26 février 2024
ECFS standards of care on CFTR-related disorders: Towards a comprehensive program for affected individuals.
Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society   21 février 2024
Lumacaftor/Ivacaftor Population Pharmacokinetics in Pediatric Patients with Cystic Fibrosis: A First Step Toward Personalized Therapy.
Clinical pharmacokinetics   04 février 2024
Representation and quantification of module activity from omics data with rROMA.
NPJ systems biology and applications   19 janvier 2024
Gathering real-world compassionate data to expand eligibility to elexacaftor-tezacaftor-ivacaftor in people with cystic fibrosis with N1303K or other rare variants: a viewpoint.
The European respiratory journal   19 janvier 2024
Reply to the letter Regarding the article entitled "Standards for the care of people with CF: a timely and accurate diagnosis".
Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society   23 décembre 2023
Putting bicarbonate on the spot: pharmacological insights for CFTR correction in the airway epithelium.
Frontiers in pharmacology   11 décembre 2023
Airway environment drives the selection of quorum sensing mutants and promote Staphylococcus aureus chronic lifestyle.
Nature communications   08 décembre 2023
PED-COVID: Seroprevalence and Antibody Profiling Against SARS-CoV2 in Children and Their Parents
Essai Clinique (Assistance publique – Hôpitaux de Paris)   14 novembre 2023